GB2366565B - Extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber Officinale and pharmaceuticals containing said extract - Google Patents

Extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber Officinale and pharmaceuticals containing said extract

Info

Publication number
GB2366565B
GB2366565B GB0114693A GB0114693A GB2366565B GB 2366565 B GB2366565 B GB 2366565B GB 0114693 A GB0114693 A GB 0114693A GB 0114693 A GB0114693 A GB 0114693A GB 2366565 B GB2366565 B GB 2366565B
Authority
GB
United Kingdom
Prior art keywords
extract
potent
inflammation
platelet aggregation
zingiber officinale
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0114693A
Other versions
GB0114693D0 (en
GB2366565A (en
Inventor
Tian-Shung Wu
Sheng-Chu Kuo
Che-Ming Teng
Feng-Nien Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaceutical Industry Technology and Development Center
Original Assignee
Pharmaceutical Industry Technology and Development Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaceutical Industry Technology and Development Center filed Critical Pharmaceutical Industry Technology and Development Center
Publication of GB0114693D0 publication Critical patent/GB0114693D0/en
Publication of GB2366565A publication Critical patent/GB2366565A/en
Application granted granted Critical
Publication of GB2366565B publication Critical patent/GB2366565B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
GB0114693A 2000-07-12 2001-06-15 Extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber Officinale and pharmaceuticals containing said extract Expired - Fee Related GB2366565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW089113895A TWI290469B (en) 2000-07-12 2000-07-12 Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component

Publications (3)

Publication Number Publication Date
GB0114693D0 GB0114693D0 (en) 2001-08-08
GB2366565A GB2366565A (en) 2002-03-13
GB2366565B true GB2366565B (en) 2005-02-16

Family

ID=21660367

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0114693A Expired - Fee Related GB2366565B (en) 2000-07-12 2001-06-15 Extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber Officinale and pharmaceuticals containing said extract

Country Status (6)

Country Link
JP (1) JP4052819B2 (en)
CH (1) CH692272A5 (en)
DE (1) DE10128266B4 (en)
FR (1) FR2811573B1 (en)
GB (1) GB2366565B (en)
TW (1) TWI290469B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109641025A (en) * 2016-05-30 2019-04-16 西姆莱斯股份公司 Drug containing race CO2 extract

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030919A1 (en) * 2001-10-11 2003-04-17 Centro De Investigación Y Desarrollo De Medicamentos. Method of obtaining an extract of ginger
JP4495406B2 (en) * 2003-04-21 2010-07-07 株式会社武蔵野免疫研究所 Sendangusa plant extract-containing composition
KR100623003B1 (en) 2004-12-22 2006-09-14 전북대학교산학협력단 Manufacturing Method of Ginger Extract using Ultrasonication
JP4849388B2 (en) * 2005-03-03 2012-01-11 国立大学法人名古屋大学 Physiologically active substance and method for producing the same, tasting method of pungent physiologically active substance, and health / medical composition
JP2008156297A (en) * 2006-12-25 2008-07-10 Hokkaido Univ Serotonin 2b and/or 2c receptor antagonist
MX2009007345A (en) * 2007-01-08 2010-02-22 Androscience Corp Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof.
GB2453728B (en) * 2007-10-16 2009-11-04 Medical & Pharmaceutical Indus Use of a potent product extracted from rhizomes of zingiber offcinale in preparation of a medicament for treatment gastritis, gastric ulcer and duodenal ulcer
US7842318B2 (en) * 2007-10-18 2010-11-30 Medical And Pharmaceutical Industry Technology And Development Center Use of a potent product extracted from rhizomes of Zingiber officinale in treating a disease associated with Helicobacter pylori
KR101481040B1 (en) 2008-03-31 2015-01-14 한국화학연구원 Composition for anti-inflammation comprising [10]-gingerdione or 1-dehydro-[10]-gingerdione
JP5103296B2 (en) * 2008-06-23 2012-12-19 花王株式会社 Method for producing purified ginger oleoresin
JP5375050B2 (en) * 2008-11-28 2013-12-25 ユーハ味覚糖株式会社 Processed ginger processed food composition and method for producing the same
SI2379092T1 (en) * 2009-01-20 2014-03-31 Indena S.P.A. Compositions comprising a lipophilic extract of zingiber officinale and an extract of cynara scolymus
ITMI20090049A1 (en) * 2009-01-20 2010-07-21 Indena Spa COMPOSITIONS BASED ON LIPOFILE EXTRACTS OF ZINGIBER OFFICINALE AND ECHINACEA ANGUSTIFOLIA FOR THE PREVENTION AND TREATMENT OF GASTRO-ESOPHAGEAL REFLOW AND CHEMOTHERAPY-INDUCED EMESIS
JP2012051811A (en) * 2010-08-31 2012-03-15 House Foods Corp Immunoenhancing agent
KR101324926B1 (en) * 2011-01-28 2013-11-01 계명대학교 산학협력단 Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same
CN102965197A (en) * 2011-09-02 2013-03-13 贵州百灵企业集团制药股份有限公司 Method for extracting and separating ginger essential oil and ginger oil resin enriched in gingerol
KR101347910B1 (en) 2012-01-31 2014-01-08 계명대학교 산학협력단 a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented
CN102657841A (en) * 2012-06-08 2012-09-12 桂林三金药业股份有限公司 Ginger phenols extract preparation and preparation method thereof
JP6030889B2 (en) * 2012-08-27 2016-11-24 辻製油株式会社 Method for producing composition for improving bone metabolism
CN103040713B (en) * 2012-12-29 2015-07-29 青岛华仁技术孵化器有限公司 A kind of Chinese medicine hair cream preventing and treating seborrheic alopecia, head pruritus
CN103751073B (en) * 2014-02-26 2015-04-22 广东轻工职业技术学院 Compound traditional Chinese medicine extract with function of removing dandruff, and application
EP3097905B1 (en) * 2015-05-28 2020-11-04 Symrise AG Cosmetic compositions
AU2018267649B2 (en) * 2016-04-27 2021-03-04 Vladimir Badmaev Method maintaining iron homeostasis with shogaols
CA3026135A1 (en) * 2016-05-30 2017-12-21 Symrise Ag Cosmetic compositions comprising sclareolide
KR102156700B1 (en) 2017-07-20 2020-09-16 고려대학교 세종산학협력단 Gingerol derivatives having a biofilm formation inhibiting ability and a pharmaceutical composition for preventing or treating infection caused by biofilm as an active ingredient thereof
WO2019017709A1 (en) * 2017-07-20 2019-01-24 고려대학교 세종산학협력단 Gingerol derivative having inhibitory activity against biofilm formation and pharmaceutical composition comprising same as effective ingredient for preventing or treating biofilm-caused infection symptom
JP6890801B2 (en) * 2018-06-08 2021-06-18 中野Ｂｃ株式会社 Manufacturing method of processed ginger products
KR102079065B1 (en) * 2019-08-02 2020-02-19 경희대학교 산학협력단 Pharmaceutical composition comprising dehydro-6-gingerdione for prevention or treatment of metabolic disease
CN111135135B (en) * 2020-02-11 2022-08-02 广州栋方生物科技股份有限公司 Ginger powder with mite removing and acne removing effects and preparation method and application thereof
KR102647997B1 (en) * 2021-06-15 2024-03-18 주식회사 제넨셀 Composition for preventing, improving, or treating degenerative arthritis comprising steamed ginger extract or 1-dehydro-6-gingerdione isolated therefrom as an active ingredient

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239736A (en) * 1985-08-15 1987-02-20 Chino Corp Scanning type radiation thermometer
JPS6372625A (en) * 1986-09-12 1988-04-02 Tsumura & Co Blood platelet agglutination inhibitor
JPH0585931A (en) * 1991-09-26 1993-04-06 Japan Tobacco Inc Leucotrienes biosynthesis inhibitor
GB2286120A (en) * 1992-05-21 1995-08-09 Jefferey Jay Staggs Therapeutic uses of pungent botanicals and their related compounds
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor
JPH10182346A (en) * 1996-12-27 1998-07-07 Kose Corp Cosmetic
WO2000002569A2 (en) * 1998-07-13 2000-01-20 Dalidar Pharma Israel (1995) Ltd. Compositions for the treatment of atherosclerosis and related conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675685A5 (en) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
DE19716660C2 (en) * 1997-04-22 2002-11-14 Schwabe Willmar Gmbh & Co Preparations, in particular pharmaceutical and pharmaceutical forms based on plants, for combating Helicobacter pylori infections
WO1999035116A1 (en) * 1998-01-09 1999-07-15 Ida Development A/S Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
DE19859499C2 (en) * 1998-12-22 2002-10-24 Schwabe Willmar Gmbh & Co Stable ginger extract preparation
US6274177B1 (en) * 2000-08-26 2001-08-14 National Science Council Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239736A (en) * 1985-08-15 1987-02-20 Chino Corp Scanning type radiation thermometer
JPS6372625A (en) * 1986-09-12 1988-04-02 Tsumura & Co Blood platelet agglutination inhibitor
JPH0585931A (en) * 1991-09-26 1993-04-06 Japan Tobacco Inc Leucotrienes biosynthesis inhibitor
GB2286120A (en) * 1992-05-21 1995-08-09 Jefferey Jay Staggs Therapeutic uses of pungent botanicals and their related compounds
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor
JPH10182346A (en) * 1996-12-27 1998-07-07 Kose Corp Cosmetic
WO2000002569A2 (en) * 1998-07-13 2000-01-20 Dalidar Pharma Israel (1995) Ltd. Compositions for the treatment of atherosclerosis and related conditions

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts 105:224787 *
MEDLINE ABSTRACT OF SHI ET AL, JOURNAL OF CHINESE MEDICINAL MATERIALS, 22 (3), 1999, PAGES 134-5 *
WPI Abstract accession no. 1988-129530 [19] & JP 630072625 A (TSUMARA) 02.04.1988 (see abstract) *
WPI ABSTRACT ACCESSION NO. 1988-129530 [19] & JP 630072625 A (TSUMURA) 02.04.1988 *
WPI Abstract accession no. 1993-149138 [18] & JP 050085931 A (JAPAN TOBACCO) 06.04.1993 (see abstract) *
WPI ABSTRACT ACCESSION NO. 1994-313611 [39] & JP 620039736 A (POLA CHEM) 30.08.94 *
WPI Abstract accession no. 1998-433681 [37] & JP 100182346 A (KOSE) 07.07.1998 (see abstract) *
WPI Abstract accession no. 2003-211367 [21] & CN 001163758 A (YUWEN) 05.11.1997 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109641025A (en) * 2016-05-30 2019-04-16 西姆莱斯股份公司 Drug containing race CO2 extract

Also Published As

Publication number Publication date
JP4052819B2 (en) 2008-02-27
DE10128266B4 (en) 2006-05-24
DE10128266A1 (en) 2002-03-14
FR2811573A1 (en) 2002-01-18
TWI290469B (en) 2007-12-01
JP2002047195A (en) 2002-02-12
CH692272A5 (en) 2002-04-30
FR2811573B1 (en) 2006-05-19
GB0114693D0 (en) 2001-08-08
GB2366565A (en) 2002-03-13

Similar Documents

Publication Publication Date Title
GB2366565B (en) Extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber Officinale and pharmaceuticals containing said extract
MXPA03005923A (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines.
GB2381536B (en) Hardfacing alloy, methods, and products
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
HUP0301146A3 (en) 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
AU9684401A (en) Hedgehog antagonists, methods and uses related thereto
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
CZ20023753A3 (en) Substituted thioacetamides, their use for preparing a medicament and pharmaceutical preparation in which the thioacetamides are comprised
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
EP1257255A4 (en) Therapeutic product, use and formulation thereof
EP1291362A4 (en) A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
AU2001275778A1 (en) Lemon extract and treatment methods
WO2004067018A8 (en) Bioavailability enhancing activity of carum carvi extracts and fractions thereof
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
MXPA03006162A (en) Mikanolide derivatives, their preparation and therapeutic uses.
MXPA03000975A (en) Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2, 4-thiazolidinedione-type derivative.
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
IL163683A0 (en) Substituted 3-phenyl-5-alkoxy-1,3,4,-oxadiazol-2-ones, their preparation and use in medicaments
MXPA01011611A (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them.
AP2250A (en) Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis.
GB0109384D0 (en) Pharmaceutical products, preparation and uses thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20110615